{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:17:10Z","timestamp":1761182230044,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.alit.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T01:10:06Z","timestamp":1469754606000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)"],"prefix":"10.1016","volume":"66","author":[{"given":"Kazuhiro","family":"Hashiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2016.06.009_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2332\/allergolint.14-RAI-0768","article-title":"Japanese guideline for allergic rhinitis 2014","volume":"63","author":"Okubo","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.06.009_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2222.2005.00099.x","article-title":"The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper","volume":"6","author":"Day","year":"2006","journal-title":"Clin Exp Allergy Rev"},{"key":"10.1016\/j.alit.2016.06.009_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1472-9733.2012.01164.x","article-title":"Experience with an allergen challenge chamber for clinical trials in allergic rhinitis","volume":"12","author":"Krug","year":"2012","journal-title":"Clin Exp Allergy Rev"},{"year":"2000","series-title":"Allergic Rhinitis: Clinical Development Programs for Drug Products","author":"U.S. Department of Health and Human Services","key":"10.1016\/j.alit.2016.06.009_bib4"},{"year":"2004","series-title":"Guideline on the Clinical Development of Medicinal Products for the Treatment of Allergic Rhinoconjunctivitis","author":"Committee for Medicinal Products for Human Use","key":"10.1016\/j.alit.2016.06.009_bib5"},{"key":"10.1016\/j.alit.2016.06.009_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2332\/allergolint.O-06-453","article-title":"Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber)","volume":"56","author":"Hashiguchi","year":"2007","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.06.009_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1472-9733.2008.00133.x","article-title":"Pilot study of Japanese cedar pollen exposure using a novel artificial exposure chamber (OHIO Chamber)","volume":"8","author":"Hashiguchi","year":"2008","journal-title":"Clin Exp Allergy Rev"},{"key":"10.1016\/j.alit.2016.06.009_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000189197","article-title":"Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis","volume":"149","author":"Hashiguchi","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2016.06.009_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14656560902758368","article-title":"Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber)","volume":"10","author":"Hashiguchi","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.alit.2016.06.009_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2500\/aap.2012.33.3517","article-title":"Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO chamber","volume":"33","author":"Wakabayashi","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.alit.2016.06.009_bib11","first-page":"173","article-title":"Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan","volume":"17","author":"Enomoto","year":"2007","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.alit.2016.06.009_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2500\/aap.2012.33.3594","article-title":"Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber","volume":"33","author":"Yamamoto","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.alit.2016.06.009_bib13","first-page":"2208","article-title":"[Artificial exposure chamber (OHIO) trial: inhibitory effect of bepotastine-OD for nasal allergy III (ACTION III study)]","volume":"61","author":"Kanzaki","year":"2012","journal-title":"[J\u00a0New Rem Clin]"},{"key":"10.1016\/j.alit.2016.06.009_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11882-015-0514-4","article-title":"Controlled allergen challenge facilities and their unique contributions to allergic rhinitis research","volume":"15","author":"North","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.alit.2016.06.009_bib15","unstructured":"Ilaxten 20 mg Tablets. Bilastine 20 mg. Summary of Product Characteristics. Available at URL: http:\/\/www.mhra.gov.uk\/spc-pil\/?prodName=ILAXTEN20MG TABLETS&subs Name =&pageID=ThirdLevel&searchTerm=bilastine#retainDisplay [accessed 27.11.15]."},{"key":"10.1016\/j.alit.2016.06.009_bib16","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1365-2222.2009.03257.x","article-title":"Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study","volume":"39","author":"Kuna","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2016.06.009_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1398-9995.2008.01813.x","article-title":"Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients","volume":"64","author":"Bachert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2016.06.009_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00011-009-0117-4","article-title":"The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber","volume":"59","author":"Horak","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.alit.2016.06.009_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2332\/allergolint.10-OA-0264","article-title":"Evaluating the effects of testing period on pollinosis symptoms using an allergen challenge chamber","volume":"60","author":"Yuki","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.06.009_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000350926","article-title":"Randomized double-blind study of prophylactic treatment with an antihistamine for seasonal allergic rhinitis","volume":"162","author":"Yonekura","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2016.06.009_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1081-1206(10)63062-1","article-title":"Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2016.06.009_bib22","first-page":"33","article-title":"Quantitative intranasal pollen changes. III. The priming effect in allergic rhinitis","volume":"43","author":"Connell","year":"1969","journal-title":"J\u00a0Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389301630096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389301630096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:05:47Z","timestamp":1761156347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S132389301630096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S132389301630096X"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2016.06.009","relation":{},"ISSN":["1323-8930"],"issn-type":[{"type":"print","value":"1323-8930"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}